Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05678543Recruiting
Diabetes family registry for mothers, partners, and children
This study builds a registry to learn about diabetes in families over time. It includes mothers with diabetes, their partners, and their children, to help researchers understand how diabetes affects families.
AalborgAges 18 years+ - NCT06362343Recruiting
Personalized dosing study for Xa inhibitor blood thinners
This study looks at how the body processes a certain type of blood thinner (Xa factor inhibitors) to help doctors find the right dose for each person. If you have a blood clot in your lungs and are on long-term treatment, this trial might help improve your care.
Beijing, Beijing MunicipalityAges 18–120 - NCT06363006RecruitingPhase 1
Cardonizumab plus TKI for advanced liver cancer after prior treatment
This trial tests a combination of an immunotherapy drug (Cardonizumab) and a targeted therapy pill (TKI) for people with advanced liver cancer whose prior treatment has stopped working. The goal is to see if this second-line combination can help shrink tumors or slow the disease.
Beijing, Beijing MunicipalityAges 18–75 - NCT06361589Recruiting
Lorlatinib for advanced ALK-positive lung cancer
This study is testing a targeted therapy called lorlatinib in people with advanced ALK-positive lung cancer. It aims to see how well this oral medication works in a real-world setting.
Chengdu, SichuanAges 18 years+ - NCT06363604Recruiting
Alcohol injection with ablation for persistent atrial fibrillation
This trial is testing a new approach to treat persistent atrial fibrillation (a type of irregular heartbeat) by combining standard catheter ablation with a special injection of alcohol (ethanol) into certain heart veins. It may help people whose symptoms haven't improved with medication.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT05938972Recruiting
Study of biologic medicines in severe CRSwNP patients
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
GhentAges 18–80 - NCT06123975Recruiting
Adenomyosis and infertility: immune factors trial
This study tests if treating immune system factors can help women with adenomyosis who are having trouble getting pregnant. It aims to see if addressing these immune aspects improves pregnancy chances.
BeijingAges 18–40 - NCT05754372Recruiting
Dialysis-focused treatment study for newborn high ammonia
This trial looks at how to best treat newborns with very high ammonia in the blood when urgent dialysis is needed. It may help doctors choose the most effective way to rapidly lower ammonia and improve outcomes in babies with certain inherited metabolic conditions.
GhentAges Up to 1 year - NCT06149130RecruitingPhase 2
Testing adebrelimab, dalpiciclib, and hormone therapy for advanced breast cancer
This trial tests a combination of a new immunotherapy drug (adebrelimab) with a targeted pill (dalpiciclib) and standard hormone therapy for women with advanced hormone receptor positive, HER2 negative breast cancer. It may help patients who have not yet had certain prior treatments, aiming to slow the cancer's growth.
Wuhan, HubeiAges 18–75 - NCT06367946Recruiting
Why ventilators can hurt older lungs
This study looks at how mechanical ventilation affects the lungs of elderly people. Researchers will study lung tissue and blood samples from patients having surgery to find ways to prevent lung injury.
ShanghaiAges Any age - NCT06364670Recruiting
Acupuncture for tinnitus: brain imaging study
This study is testing whether acupuncture can help treat tinnitus by using a special brain imaging technique (fNIRS) to see how the brain responds. It may help find out who benefits most from acupuncture.
Hangzhou, ZhejiangAges 18–60 - NCT06365138Recruiting
Activity at the time of aortic rupture in aneurysm patients
This study looks at what patients were doing just before their aortic aneurysm ruptured, to help understand possible triggers. It is a simple observational study that asks about your activity at the time of rupture.
AugsburgAges 18 years+ - NCT06352216Recruiting
Joint inflammation in hemophilia A patients
This study looks at how many adults with moderate or severe hemophilia A have inflammation in their joints (synovitis). It aims to better understand joint health in people with hemophilia A, including those with inhibitors or joint replacements.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT06364878Recruiting
Non-invasive diagnosis for eye infections
This study tests a new, non-invasive (no needles or surgery) way to diagnose a type of eye infection called microbial keratitis. It may help find the cause faster so you get the right treatment sooner.
ArendalAges 18 years+ - NCT04547725Recruiting
Surgery plus chemotherapy for stomach cancer in the belly lining
This study tests whether a thorough surgery to remove stomach cancer in the abdomen, followed by chemotherapy given through the belly and by vein, can improve outcomes. It’s for people newly diagnosed with stomach cancer that has limited spread to the belly lining.
TaipeiAges 20–75 - NCT05828251Recruiting
Treating a fresh macular hole sooner or later
This study looks at how to manage a full-thickness macular hole that started recently, comparing different timing (“subacute” care) to see which approach helps vision best. You may be considered if your hole is small and new, and you can follow required eye positioning after treatment.
Glostrup Municipality, CopenhagenAges 18 years+ - NCT06358248Recruiting
Registry for customized endografts in complex aortic aneurysms
This registry tracks patients with complex abdominal aortic aneurysms who receive a physician-modified endograft. It aims to collect data on how well this tailored device works to treat aneurysms that standard grafts cannot handle.
PadovaAges 18–100 - NCT06363734RecruitingPhase 2
Targeted drug combo for EGFR-mutant lung cancer after resistance
This trial tests a combination of two targeted drugs (osimertinib and dalpiciclib) for people with advanced lung cancer whose tumors have a specific EGFR mutation and a change in the CDK4/6 pathway, and whose cancer has stopped responding to a third-generation EGFR targeted therapy. The goal is to see if this combination can help shrink tumors or slow cancer growth.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06360471Recruiting
Preserving fertility in women with cancer
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Nanjing, JiangsuAges 20–40 - NCT06368882RecruitingPhase 4
Peg-interferon for hepatitis B with fatty liver
This trial tests a medicine called peg-interferon for people who have both chronic hepatitis B and fatty liver. It aims to see if the treatment is safe and effective in helping your body fight the hepatitis B virus.
NingboAges 18–60 - NCT06368154Recruiting
Studying early markers for brittle bones in newborns
This trial looks for tiny particles in the blood that might help doctors detect bone weakness in premature babies. It aims to find early signs of metabolic bone disease, which could lead to better care.
Changsha, HunanAges birth–3 days - NCT02434003Recruiting
Test a new way to predict scoliosis curve progression
This study follows adolescents with idiopathic scoliosis to see how well a new predictive model estimates whether the spinal curve will get worse over time. It may help doctors plan monitoring and treatment more accurately for young people with scoliosis.
San Diego, CaliforniaAges 10–15 - NCT06371586RecruitingPhase 2
Neo-Sequence 2: New drug combo for advanced stomach cancer
This trial tests a new treatment plan for advanced stomach cancer using chemotherapy, anti-angiogenesis therapy (to cut off tumor blood supply), and immunotherapy (to help your immune system fight cancer). The goal is to see if this combination works better before surgery.
BeijingAges 18–75 - NCT03373721Recruiting
Compare gut microbes in preterm vs full-term babies
This study looks at differences in the gut bacteria of babies born early (preterm) compared with babies born full-term. It may help researchers understand how early birth affects early health and gut development.
ShanghaiAges 1 day–4 months
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,157 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.